News for GEHC Stock

GE HealthCare to announce second quarter 2025 results on July 30, 2025 GE HealthCare announces cash dividend for second quarter of 2025 FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025 GE HealthCare drives innovation in theranostics with latest technological advances Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions GE HealthCare reports first quarter 2025 financial results GE HealthCare management to present at upcoming investor conferences GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium GE HealthCare to announce first quarter 2025 results on April 30, 2025 Cincinnati Children’s and GE HealthCare build collaborative research program to drive pediatric imaging innovation GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions GE HealthCare announces cash dividend for first quarter of 2025 ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Portfolio to Improve Speed of Digital Innovation Adoption GE HealthCare names new president and CEO, China GE HealthCare unveils Freelium, a next-generation sealed magnet platform at ECR 2025 to support equitable and sustainable access to MR Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection GE HealthCare reports fourth quarter and full year 2024 financial results GE HealthCare management to present at upcoming investor conference GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand GE HealthCare named to 2025 Fortune World’s Most Admired Companies™ list GE HealthCare unveils enhanced Voluson Expert Series women’s health ultrasound systems with focus on early detection and exam efficiency University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025 GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide GE HealthCare showcases commitment to sustainable innovation at RSNA 2024 GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024 GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care GE HealthCare management to present at upcoming investor conferences GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™ GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares GE HealthCare to Host its 2024 Investor Day on November 21 GE HealthCare reports third quarter 2024 financial results GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging GE HealthCare to announce third quarter 2024 results on October 30, 2024 GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024 GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint GE HealthCare announces cash dividend for third quarter of 2024 GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024 GE HealthCare management to present at September investor conferences Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care GE HealthCare to Embark on a Collaboration to Elevate Women’s Imaging GE HealthCare reports second quarter 2024 financial results GE HealthCare and AWS Announce Strategic Collaboration to Accelerate Healthcare Transformation With Generative AI GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound GE HealthCare to announce second quarter 2024 results on July 31, 2024 GE HealthCare announces cash dividend for second quarter of 2024 Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures GE HealthCare and MediView Announce the World';s First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World GE HealthCare Pharmaco-Economic Study Demonstrates Adding Breast Oncology PET Tracer to Standard Workup of Patients with Metastatic or Recurrent Breast Cancer May Yield Beneficial Clinical and Economic Outcomes, Potentially Saving $142M Over Five... GE HealthCare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease GE HealthCare to Hold an Investor Day in New York City on November 21, 2024 Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS GE HealthCare Management to Present at Upcoming Investor Conferences GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress GE HealthCare Reports First Quarter 2024 Financial Results GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions GE HealthCare’s MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024 GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health GE HealthCare Announces Cash Dividend for First Quarter of 2024 GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024 GE HealthCare Accelerates AI Innovation with Healthcare-Specific Foundation Models Powered by NVIDIA GE HealthCare and Hartford HealthCare Renew and Evolve 7-Year Collaboration to Advance Patient Care and Access in Connecticut GE HealthCare Establishes the GE HealthCare Foundation GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 14,000,000 Shares GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares GE HealthCare and Mass General Brigham Evolve Their AI Collaboration with Medical Imaging Foundation Models GE HealthCare to Spotlight Industry-Leading AI-Enabled Portfolio and Digital Solutions at HIMSS 2024 GE HealthCare Showcases Precision Care with Launch of Elevated LOGIQ Ultrasound System Portfolio at European Congress of Radiology 2024 GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions Serving Patients and Communities Through Comprehensive Care Solutions: OSF HealthCare, Pointcore, Inc. and GE HealthCare Enter Strategic Care Alliance GE HealthCare Technologies Inc. Prices Secondary Offering of 13,000,000 Shares GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares GE HealthCare Management to Present at Upcoming Investor Conferences GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results Novii+ Wireless Maternal and Fetal Monitoring Solution Cleared by the FDA for Monitoring Approximately 95% of All Eligible Births in the United States¹ GE HealthCare Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024 GE HealthCare announces agreement to acquire MIM Software GE HealthCare Management to Present at 42nd Annual J.P. Morgan Healthcare Conference GE HealthCare Announces Cash Dividend for Fourth Quarter of 2023 Nantworks AirStrip® and GE HealthCare Announce Agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023 GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection GE HealthCare Showcases More Than 40 Innovations, Including AI-Enabled Imaging Technology Solutions Designed for Precision Care at RSNA23 GE HealthCare Announces New Version of Digital Expert Access, the First FDA 510(k)-Cleared Device to Enable Remote Patient Scanning, and Exclusive Distribution Agreement with IONIC Health University of Wisconsin–Madison and GE HealthCare Broaden Shared Commitment to Healthcare Innovation GE HealthCare to Hold Fireside Chat with Citi Medtech Analyst at RSNA 2023 Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies GE HealthCare Reports Third Quarter 2023 Financial Results GE HealthCare and reLink Medical Collaborate to Help Reduce Medical Device Waste for Healthcare Providers GE HealthCare Tops List with Highest Number of AI-Enabled Medical Device Authorizations, Developing Innovative Solutions for Precision Care GE HealthCare Announces New Innovations and Collaborations in Image Guided Therapy as part of TCT2023 Cardiology Care Pathway Showcase GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound GE HealthCare to Announce Third Quarter 2023 Results on October 31, 2023 GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers GE HealthCare’s growing list of medical institutions conducting human subject research studies with its novel photon counting CTi technology further expands with the addition of Stanford Medicine GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes GE HealthCare Announces Cash Dividend for Third Quarter of 2023 GE HealthCare Shares Key Focus Areas and Future Goals in its Inaugural Sustainability Report GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries Mayo Clinic and GE HealthCare Enter Strategic Collaboration to Advance Innovation in Medical Imaging and Theranostics GE HealthCare and Mass General Brigham Collaborate on an AI Algorithm to Predict Missed Care Opportunities GE HealthCare Introduces Vscan Air SL, a Wireless Handheld Ultrasound Device for Rapid Assessments of Cardiac and Vascular Patients GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care GE HealthCare Management to Present at September Investor Conferences Genpact to Streamline US Leasing and Lending Operations for GE HealthCare with AI-Powered Platform Genpact Cora GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration GE HealthCare Reports Second Quarter 2023 Financial Results GE HealthCare to Announce Second Quarter 2023 Results on July 25, 2023 From General to Personalized Care: GE HealthCare is Focused on Disease Detection and More Holistic and Effective Treatment Options GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023 GE HealthCare Advances PET/MR Capabilities with AIR Technologies GE HealthCare Announces Collaboration with DePuy Synthes to Bring Advanced 3D Precision Imaging Innovation to Spine Practices in the United States First Ever Investigational ¹⁸F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies GE HealthCare Technologies Inc. Prices Secondary Offering of 25,000,000 Shares GE HealthCare Reimagining Better Health Study Identifies the Barriers to Achieving a More Human and Flexible Healthcare Experience GE HealthCare Technologies Inc. Commences Secondary Offering of 25,000,000 Shares GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI St. Luke’s University Health Network Selects GE HealthCare for $30 Million Purchase of Cutting-Edge CT Technology, Powered by Artificial Intelligence GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) GE HealthCare to Present at Jefferies Healthcare Conference GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress GE HealthCare Names James Saccaro Vice President and Chief Financial Officer GE HealthCare Expands Contrast Media Portfolio with Launch of MRI Agent Pixxoscan (gadobutrol) GE HealthCare Announces Availability of Next-Generation bkActiv for Guiding Urology, Colorectal and Pelvic Floor Surgeries GE HealthCare Reports First Quarter 2023 Financial Results GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance Advancing Precision Care: GE HealthCare Introduces an Innovative Solution to Help Expand Interventional CT Access GE HealthCare to Showcase Latest AI Innovations at HIMSS 2023 GE HealthCare to Announce First Quarter 2023 Results on April 25, 2023 Advantus Health Partners and GE HealthCare Announce Multi-Year Agreement to Expand Access to Healthcare Technology Management Services GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent SonoThera™ Receives Exclusive Licensing of GE HealthCare’s Optison® and Sonazoid® Microbubble Products for use with its Ultrasound-guided Gene Therapy Platform GE HealthCare Leaders to Present at March Investor Conferences GE HealthCare to Acquire Caption Health, Expanding Ultrasound to Support New Users Through FDA-Cleared, AI-Powered Image Guidance GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results Sound Technologies and GE HealthCare Announce Collaboration to Bring Vscan Air Handheld Ultrasound to Veterinary Practices Across the United States GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance GE HealthCare Names Health Tech Pioneer Taha Kass-Hout First Chief Technology Officer GE HealthCare Completes Spin-Off and Begins Trading on Nasdaq